Associations of U.S. state-level COVID-19 policies intensity with cannabis sharing behaviors in 2020
Abstract Background: Cannabis use before the COVID-19 pandemic for many involved sharing prepared cannabis for inhalation, practices that were less…
Abstract Background: Cannabis use before the COVID-19 pandemic for many involved sharing prepared cannabis for inhalation, practices that were less…
Abstract Objective: The drug poisoning crisis throughout North America necessitates novel harm reduction approaches. Emerging evidence suggests that cannabidiol (CBD)…
Abstract Background: Lower-risk substance use guidelines (LRSUGs) are an evidence-based harm reduction strategy used to provide information to people who…
Abstract Significance: Electronic cigarettes (e-cigarettes) aerosolise liquids that contain nicotine, propylene glycol, glycerol and appealing flavours. In the USA, regulations…
Abstract With rising numbers of drug-related deaths in the UK and globally, exploration of interventions that seek to reduce drug-related…
Abstract Introduction: Cannabidiol (CBD), the second most prevalent cannabinoid found in cannabis, is considered to be safe for use. Studies…
Abstract Background: During a COVID-19 outbreak in the congregate shelter system in Halifax, Nova Scotia, Canada, a healthcare team provided…
Abstract Background: Although cannabis use is common in France, it is still criminalized. Cannabidiol (CBD) products, including CBD-rich cannabis, are…
Abstract Rationale.: Classic psychedelics are currently being studied as novel treatments for a range of psychiatric disorders. However, research on…
Abstract The standardization of cannabis doses is a priority for research, policy-making, clinical and harm-reduction interventions and consumer security. Scientists…